These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 12653173)

  • 1. Mast cells and T cells in Kimura's disease express increased levels of interleukin-4, interleukin-5, eotaxin and RANTES.
    Kimura Y; Pawankar R; Aoki M; Niimi Y; Kawana S
    Clin Exp Allergy; 2002 Dec; 32(12):1787-93. PubMed ID: 12653173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Migration of eosinophils across endothelial cell monolayers: interactions among IL-5, endothelial-activating cytokines, and C-C chemokines.
    Shahabuddin S; Ponath P; Schleimer RP
    J Immunol; 2000 Apr; 164(7):3847-54. PubMed ID: 10725746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.
    Park CW; Lee BH; Han HJ; Lee CH; Ahn HK
    Br J Dermatol; 2005 Jun; 152(6):1173-81. PubMed ID: 15948978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-C chemokines in allergen-induced late-phase cutaneous responses in atopic subjects: association of eotaxin with early 6-hour eosinophils, and of eotaxin-2 and monocyte chemoattractant protein-4 with the later 24-hour tissue eosinophilia, and relationship to basophils and other C-C chemokines (monocyte chemoattractant protein-3 and RANTES).
    Ying S; Robinson DS; Meng Q; Barata LT; McEuen AR; Buckley MG; Walls AF; Askenase PW; Kay AB
    J Immunol; 1999 Oct; 163(7):3976-84. PubMed ID: 10491000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of the chemokine receptor CCR3 on human mast cells.
    de Paulis A; Annunziato F; Di Gioia L; Romagnani S; Carfora M; Beltrame C; Marone G; Romagnani P
    Int Arch Allergy Immunol; 2001; 124(1-3):146-50. PubMed ID: 11306952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine receptor usage by human eosinophils. The importance of CCR3 demonstrated using an antagonistic monoclonal antibody.
    Heath H; Qin S; Rao P; Wu L; LaRosa G; Kassam N; Ponath PD; Mackay CR
    J Clin Invest; 1997 Jan; 99(2):178-84. PubMed ID: 9005985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of RANTES, CCR3 and CCR5 in the lesional skin of patients with atopic eczema.
    Kato Y; Pawankar R; Kimura Y; Kawana S
    Int Arch Allergy Immunol; 2006; 139(3):245-57. PubMed ID: 16449815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-16 promotes leukotriene C(4) and IL-4 release from human eosinophils via CD4- and autocrine CCR3-chemokine-mediated signaling.
    Bandeira-Melo C; Sugiyama K; Woods LJ; Phoofolo M; Center DM; Cruikshank WW; Weller PF
    J Immunol; 2002 May; 168(9):4756-63. PubMed ID: 11971026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptase-chymase double-positive human mast cells express the eotaxin receptor CCR3 and are attracted by CCR3-binding chemokines.
    Romagnani P; De Paulis A; Beltrame C; Annunziato F; Dente V; Maggi E; Romagnani S; Marone G
    Am J Pathol; 1999 Oct; 155(4):1195-204. PubMed ID: 10514402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mast cell beta-tryptase selectively cleaves eotaxin and RANTES and abrogates their eosinophil chemotactic activities.
    Pang L; Nie M; Corbett L; Sutcliffe A; Knox AJ
    J Immunol; 2006 Mar; 176(6):3788-95. PubMed ID: 16517749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eotaxin/CCL11 in idiopathic retroperitoneal fibrosis.
    Mangieri D; Corradi D; Martorana D; Malerba G; Palmisano A; Libri I; Bartoli V; Carnevali ML; Goldoni M; Govoni P; Alinovi R; Buzio C; Vaglio A
    Nephrol Dial Transplant; 2012 Oct; 27(10):3875-84. PubMed ID: 23114905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminooxypentane-RANTES induces CCR3 activation and internalization of CCR3 from the surface of human eosinophils.
    Elsner J; Dulkys Y; Kimmig D; Wells TN; Proudfoot AE; Kapp A
    Int Arch Allergy Immunol; 2001; 124(1-3):227-9. PubMed ID: 11306977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin.
    Penido C; Castro-Faria-Neto HC; Vieira-de-Abreu A; Figueiredo RT; Pelled A; Martins MA; Jose PJ; Williams TJ; Bozza PT
    Am J Respir Cell Mol Biol; 2001 Dec; 25(6):707-16. PubMed ID: 11726396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemokines in the limbal form of vernal keratoconjunctivitis.
    Abu El-Asrar AM; Struyf S; Al-Kharashi SA; Missotten L; Van Damme J; Geboes K
    Br J Ophthalmol; 2000 Dec; 84(12):1360-6. PubMed ID: 11090473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High expression of the chemokine receptor CCR3 in human blood basophils. Role in activation by eotaxin, MCP-4, and other chemokines.
    Uguccioni M; Mackay CR; Ochensberger B; Loetscher P; Rhis S; LaRosa GJ; Rao P; Ponath PD; Baggiolini M; Dahinden CA
    J Clin Invest; 1997 Sep; 100(5):1137-43. PubMed ID: 9276730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CC chemokine antagonist Met-RANTES inhibits eosinophil effector functions through the chemokine receptors CCR1 and CCR3.
    Elsner J; Petering H; Höchstetter R; Kimmig D; Wells TN; Kapp A; Proudfoot AE
    Eur J Immunol; 1997 Nov; 27(11):2892-8. PubMed ID: 9394815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid.
    Frezzolini A; Teofoli P; Cianchini G; Barduagni S; Ruffelli M; Ferranti G; Puddu P; De Pita O
    Eur J Dermatol; 2002; 12(1):27-31. PubMed ID: 11809592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Th2 cytokines, RANTES and eotaxin in AIDS-associated eosinophilic folliculitis.
    Amerio P; Verdolini R; Proietto G; Feliciani C; Toto P; Shivji G; Loconsole F; Cassano N; Amerio P; Vena G; Sauder DN
    Acta Derm Venereol; 2001 May; 81(2):92-5. PubMed ID: 11501668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-16 activates plasminogen-plasmin system and promotes human eosinophil migration into extracellular matrix via CCR3-chemokine-mediated signaling and by modulating CD4 eosinophil expression.
    Ferland C; Flamand N; Davoine F; Chakir J; Laviolette M
    J Immunol; 2004 Oct; 173(7):4417-24. PubMed ID: 15383572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eotaxin/CCL11 suppresses IL-8/CXCL8 secretion from human dermal microvascular endothelial cells.
    Cheng SS; Lukacs NW; Kunkel SL
    J Immunol; 2002 Mar; 168(6):2887-94. PubMed ID: 11884459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.